MedTrace Logo

A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder

NCT03078270 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2019-01-23

Study results available
· View outcomes & findings →

Summary

The goal of this study is to see whether Botox is an effective treatment for social anxiety disorder (SAD). Participants will complete two short surveys on depression and anxiety symptoms, receive a one-time injection of Botox, and complete the depression and anxiety survey 4 weeks after injection and again at 8 weeks after injection.

Conditions

Interventions

DRUG

botulinum toxin A

Single treatment visit for 5 injections of botulinum toxin A, 40 units (for females) and 50 units (for males)/

OTHER

Placebo

single treatment visit for 5 injections of normal saline

Sponsors & Collaborators

  • Daniel Lieberman

    lead OTHER

Principal Investigators

  • Daniel Z Lieberman, MD · George Washington University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2017-09-12
Completion
2017-09-12
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03078270 on ClinicalTrials.gov